Literature DB >> 21279158

Immunoexpression of Survivin in non-neoplastic lymphoid tissues and malignant lymphomas using a new monoclonal antibody reactive on paraffin sections.

José Vassallo, Talal Al Saati, Randy D Gascoyne, Kathyrn Welsh, John C Reed, Pierre Brousset, Georges Delsol.   

Abstract

Survivin is a member of the inhibitor of apoptosis gene family, which is also implicated in mitosis regulation. Most reports in the literature impute poor prognosis to neoplasms with overexpression of this protein. The purpose of the present study is to validate and compare the immunohistochemical reactivity of malignant lymphomas and reactive lymphoid tissue using a new mouse monoclonal antibody to Survivin produced in our laboratory, 6-78. Survivin was detected by immunohistochemistry on tissue microarrays. It was shown that the antibody anti-Survivin 6-78 reliably stains formalin-fixed, paraffin-embedded reactive and neoplastic lymphoid tissues, mostly in a nuclear pattern. We confirmed using this novel antibody that Survivin immunostaining has a tendency to be lower in reactive lymphoid tissues and low-grade B cell lymphomas than in aggressive lymphomas. This antibody may represent a useful tool for standardizing the study of the immunoexpression of Survivin in neoplasms.

Entities:  

Keywords:  Immunohistochemistry; Malignant lymphomas; Mouse monoclonal antibody 6-78; Survivin

Year:  2010        PMID: 21279158      PMCID: PMC2883904          DOI: 10.1007/s12308-009-0054-8

Source DB:  PubMed          Journal:  J Hematop        ISSN: 1865-5785            Impact factor:   0.196


  27 in total

1.  Developmentally regulated expression of survivin in the human thymus.

Authors:  Yoshihiro Kobayashi; Haruhiro Yukiue; Hidefumi Sasaki; Ichiro Fukai; Tomoki Yokoyama; Masanobu Kiriyama; Yosuke Yamakawa; Masanobu Maeda; Yoshitaka Fujii
Journal:  Hum Immunol       Date:  2002-02       Impact factor: 2.850

Review 2.  Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm.

Authors:  Dario C Altieri
Journal:  J Cell Biochem       Date:  2004-07-01       Impact factor: 4.429

Review 3.  Survivin study: what is the next wave?

Authors:  Fengzhi Li
Journal:  J Cell Physiol       Date:  2003-10       Impact factor: 6.384

4.  Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia.

Authors:  L Granziero; P Ghia; P Circosta; D Gottardi; G Strola; M Geuna; L Montagna; P Piccoli; M Chilosi; F Caligaris-Cappio
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

5.  Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

Authors:  C Adida; C Haioun; P Gaulard; E Lepage; P Morel; J Briere; H Dombret; F Reyes; J Diebold; C Gisselbrecht; G Salles; D C Altieri; T J Molina
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

6.  Overexpression of TIAP/m-survivin in thymocytes enhances cell proliferation.

Authors:  Satosi Hikita; Masahiko Hatano; Atsushi Inoue; Nobuyuki Sekita; Koichi Kobayashi; Masayuki Otaki; Takeshi Ogasawara; Seiji Okada; Hiroyuki Hirasawa; Takeshi Tokuhisa
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

7.  Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.

Authors:  Ellen J Schlette; L Jeffrey Medeiros; Andre Goy; Raymond Lai; George Z Rassidakis
Journal:  J Clin Oncol       Date:  2004-05-01       Impact factor: 44.544

8.  Excessive survivin expression in thyroid lymphomas.

Authors:  Masahiro Sugawara; Fumio Matsuzuka; Shuji Fukata; Kanji Kuma; Farhad Moatamed; Bryan R Haugen
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

9.  Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.

Authors:  Hongbin Zha; Mark Raffeld; Lu Charboneau; Stefania Pittaluga; Larry W Kwak; Emanuel Petricoin; Lance A Liotta; Elaine S Jaffe
Journal:  Lab Invest       Date:  2004-02       Impact factor: 5.662

10.  Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.

Authors:  Juan F García; Francisca I Camacho; Manuel Morente; Máximo Fraga; Carlos Montalbán; Tomás Alvaro; Carmen Bellas; Angel Castaño; Ana Díez; Teresa Flores; Carmen Martin; Miguel A Martinez; Francisco Mazorra; Javier Menárguez; Maria J Mestre; Manuela Mollejo; Ana I Sáez; Lydia Sánchez; Miguel A Piris
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

View more
  1 in total

1.  Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study.

Authors:  Sarah Adel Hakim; Hoda Hassan Abou Gabal
Journal:  Pathol Oncol Res       Date:  2021-04-09       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.